Bulldog Bio, Inc. Awarded Exclusive Distributorship of Novel Transfection Reagent Line
Published: May 15, 2012
“We’re very eager to introduce this comprehensive line of transfection tools to the North American research community.” Ella Fontaine, VP of Communications, further elaborates. “BCC’s reagents offer a completely new approach to introducing plasmid, siRNAs and proteins into the cytoplasm and nucleus of cells. We’re particularly excited about the encouraging results seen with primary and stem cells. Researchers will find these reagents effective and affordable.”
BioCellChallenge SAS is a privately held biotechnology company, founded in 2009. The company specializes in drug delivery systems and aims to provide very good tools to the scientific community so that scientists attain new heights in research.
Bulldog Bio Incorporated is a privately held company headquartered in Portsmouth, NH, that distributes tools to Life Science researchers. Please visit www.bulldog-bio.com for more information about the company and its products.